Hcc - hepatocellular carcinoma Clinical Trials
Conditions / Hcc - hepatocellular carcinoma
Delta Trials records 46 clinical trials for Hcc - hepatocellular carcinoma in its publicly accessible dataset. From the full dataset, 28 actively seeking eligible participants and 7 trials have reached completion. This research is conducted across 83 study locations around the world. An additional 11 trials are active but not currently open for enrollment. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.
Trial Status
46
Total Trials
28
Recruiting
7
Completed
11
Other Active
0
Terminated since 2020
83
Study Locations
Browse by location (83 total)
- Shanghai, China 6 trialsAll trials in Shanghai, China
- Beijing, China 5 trialsAll trials in Beijing, China
- Bologna, Italy 3 trialsAll trials in Bologna, Italy
- Hong Kong, Hong Kong 3 trialsAll trials in Hong Kong, Hong Kong
- Wuhan, China 3 trialsAll trials in Wuhan, China
- Nanjing, China 3 trialsAll trials in Nanjing, China
- Nantes, France 2 trialsAll trials in Nantes, France
- Clichy, France 2 trialsAll trials in Clichy, France
- Taoyuan, Taiwan 2 trialsAll trials in Taoyuan, Taiwan
- Guangzhou, China 2 trialsAll trials in Guangzhou, China
- Shenyang, China 2 trialsAll trials in Shenyang, China
- Bobigny, France 2 trialsAll trials in Bobigny, France
- Tainan, Taiwan 1 trialAll trials in Tainan, Taiwan
- Perpignan, France 1 trialAll trials in Perpignan, France
- Topkapı, Turkey (türkiye) 1 trialAll trials in Topkapı, Turkey (türkiye)
- Shaoyang, China 1 trialAll trials in Shaoyang, China
- Brest, France 1 trialAll trials in Brest, France
- Rouen, France 1 trialAll trials in Rouen, France
- Canton, United States 1 trialAll trials in Canton, United States
- Atlanta, United States 1 trialAll trials in Atlanta, United States